DZ BANK upgraded Fresenius (ETR:FRE) to Buy in a report released today.
- Updated: September 17, 2016
Showing a price of 69.28EUR, Fresenius (ETR:FRE) traded 0.00% even on the day. The last stock close is up 0.00% relative to the 200-day average, compared to the S&P 500 Index which has fallen -0.01% over the same time period. Fresenius has registered a 50-day moving average of 0.00EUR and two hundred day average of 0.00EUR. 0 shares of the stock traded, from ann average volume of 0
DZ BANK has upgraded Fresenius(ETR:FRE) to Buy in a statement released 9/18/2016.
Recent Performance Chart:
Fresenius has a one-year low of 0.00EUR and a 52 week high of 0.00EUR. The company’s market cap is presently 0.0 EUR.
About Fresenius (ETR:FRE)
Fresenius SE & Co KGaA is a health care company. It operates in the healthcare sector and offers products and services for dialysis, hospitals and outpatient medical care. It focuses on the hospital operations and offers engineering and services for hospitals and other health care facilities. The Company’s operating segments include Fresenius Medical Care; Fresenius Kabi; Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment provides dialysis care and dialysis products for patients with chronic kidney failure. The Fresenius Kabi segment is engaged in provision of intravenously administered drugs (IV drugs), infusion therapies, and clinical nutrition and outpatient care. The Fresenius Helios segment is a private hospital operator and operates 72 clinics. The Fresenius Vamed segment provides engineering and services for hospitals and other health care facilities internationally.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.